Cotinga Pharmaceuticals Inc. — Form D
Cotinga Pharmaceuticals Inc. of LONDON, A6, a company, filed a Form D exempt-offering notice with the SEC on 2013-09-04. The offering totals $145K, of which $46K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-09-04
- Form: D
- Accession: 0001183740-13-000337
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $145K
- Amount sold: $46K
- Remaining: $99K
- Investors: 1
- Date of first sale: 2013-08-28
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-202337
Issuer
- Name: Cotinga Pharmaceuticals Inc.
- CIK: 0001585808
- Entity type: Corporation
- Jurisdiction: ONTARIO, CANADA
- Address: SUITE 230B, THE MOGENSON CENTRE, LONDON, A6, N6G 4X8
- Phone: 519-858-5157
Officers, directors & promoters (24)
| Name | Role | Location |
|---|
| Bruno Maruzzo | Director | Toronto, A6 |
| David Sanderson | Director | San Francisco, CA |
| Brent Norton | Director | Summerville, SC |
| DAVID S SANDERSON | Director | LONDON, A6 |
| JOHN S YOO | Director | LONDON, A6 |
| GENE KELLY | Executive Officer | LONDON, A6 |
| JOHN C DRAKE | Director | LONDON, A6 |
| ALISON SILVA | Director | LONDON, A6 |
| ALISON SILVA | Executive Officer | LONDON, A6 |
| DOUGLAS S ALEXANDER | Director | LONDON, A6 |
| John Drake | Director | Denver, CO |
| BHARATT S CHOWRIRA | Director | LONDON, A6 |
| BRUNO S MARUZZO | Director | LONDON, A6 |
| ALISON S SILVA | Director | LONDON, A6 |
| WAYNE R DANTER | Director | LONDON, A6 |
| WAYNE R DANTER | Executive Officer | LONDON, A6 |
| JOHN D YOO | Director | LONDON, A6 |
| ALISON D SILVA | Director | LONDON, A6 |
| DOUGLAS ALEXANDER | Director | LONDON, A6 |
| WAYNE DANTER | Director | LONDON, A6 |
| WAYNE DANTER | Executive Officer | LONDON, A6 |
| Thomas Wellner | Director | Toronto, A6 |
| MURRAY WALLACE | Director | LONDON, A6 |
| KATHLEEN FERGUSON | Director | LONDON, A6 |
Other filings by this issuer (12)
More